Allan Reine, Chief Executive Officer at Prime Medicine, Inc. (PRME), bought 125,000 shares at $1.18 ($148K) on 2025-05-21, disclosed to the SEC on 2025-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.